VR Logo

Unrated

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund download report


1 Lakh

Investment Grown to
₹ 2.03 Lakh

₹ 10000

Monthly SIP Grown to
₹ 4.61 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
ICICI Pru Pharma Healthcare And Diagnostics (P.H.D) Fund-G -8.35 0.10 0.16 1.48 4.98 -0.72 -8.44 26.65 -- -- --
S&P BSE Healthcare TRI -10.66 0.20 0.35 3.25 3.13 -2.80 -10.64 23.91 -- -- --
Equity: Sectoral-Pharma -9.58 0.03 0.11 2.59 3.58 -1.80 -8.94 25.26 -- -- --
Rank within category 3 7 8 15 3 2 6 3 -- -- --
Number of funds in category 15 16 16 15 15 15 13 9 4 3 3

As on 17-Aug-2022

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 -8.44 26.65 -- 2.07 2,503
Nippon India Pharma Fund
Unrated
Jun-04 -9.56 26.64 17.90 1.98 4,620
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 -7.29 29.93 -- 2.10 1,738
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 -6.92 25.70 12.25 2.18 1,668
DSP Healthcare Fund - Regular Plan
Unrated
Nov-18 -9.82 28.73 -- 2.21 1,196

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 23.20 01-Apr-2020 - 09-Apr-2020 -11.57 05-Mar-2020 - 12-Mar-2020
Month 35.08 27-Mar-2020 - 27-Apr-2020 -20.50 20-Feb-2020 - 23-Mar-2020
Quarter 50.45 23-Mar-2020 - 22-Jun-2020 -14.01 23-Dec-2019 - 23-Mar-2020
Year 92.19 23-Mar-2020 - 23-Mar-2021 -12.90 02-Jul-2021 - 04-Jul-2022

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
ICICI Pru Pharma Healthcare And Diagnostics (P.H.D) Fund-G 25.17 21.94 0.99 2.25 0.96 3.16
S&P BSE Healthcare TRI 22.78 22.44 0.86 1.63 -- --
Equity: Sectoral-Pharma 23.87 20.45 1.00 1.96 0.89 3.20
Rank within category 3 9 6 2 9 5
Number of funds in category 9 9 9 9 9 9

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 31-Jul-2022

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 29
Top 10 Stocks (%) 59.05
Top 5 Stocks (%) 40.36
Top 3 Sectors (%) 96.41
Portfolio P/B Ratio 3.28
Portfolio P/E Ratio 27.24

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 36,134 56,506
Giant (%) 16.48 20.17
Large (%) 26.54 35.87
Mid (%) 46.68 36.51
Small (%) 9.56 7.35
Tiny (%) 0.75 0.54

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
equal Sun Pharmaceutical Industries Healthcare 56.51 15.74 9.13 15.74
down Dr. Reddy's Lab Healthcare 23.51 9.11 1.47 7.95
equal Lupin Healthcare -- 10.36 3.22 7.50
up Alkem Laboratories Healthcare 26.84 8.45 0.84 4.86
equal Sanofi India Healthcare 15.00 5.16 3.12 4.31
down Aster DM Healthcare Healthcare 18.98 4.31 1.36 4.27
equal Aurobindo Pharma Healthcare 14.24 4.41 0.00 3.96
down Cipla Healthcare 33.50 12.21 3.71 3.71
down Indoco Remedies Healthcare 20.71 3.93 1.74 3.37
up Torrent Pharmaceuticals Healthcare 66.12 5.00 2.49 3.37
up Natco Pharma Healthcare 28.67 3.87 0.89 3.28
equal Apollo Hospitals Healthcare 69.51 3.26 0.00 3.26
equal FDC Healthcare 23.23 3.12 0.00 2.96
down SBI Life Insurance Company Insurance 85.70 4.81 1.14 2.87
equal Fortis Healthcare Healthcare 52.97 3.32 0.00 2.84
down Ipca Laboratories Healthcare 32.57 6.33 1.28 2.28
equal Krsnaa Diagnostics Healthcare 22.00 2.46 0.00 2.16
down Zydus Lifesciences Healthcare 9.03 6.71 0.89 1.94
equal JB Chemicals & Pharma Healthcare 37.49 4.18 1.60 1.82
equal ICICI Lombard General Insurance Company Insurance 45.71 2.03 0.00 1.81
equal Biocon Healthcare 53.30 6.79 0.00 1.73
equal Glaxosmithkline Pharma Healthcare 14.77 2.14 0.00 1.70
up Gland Pharma Healthcare 36.23 2.05 0.00 1.70
equal Divi's Laboratories Healthcare 32.01 8.81 1.51 1.54
equal Narayana Hrudayalaya Healthcare 39.08 3.11 1.32 1.32

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Jul-2022

Fund Manager

— Dharmesh Kakkad since 02-May-2020

Education: Mr. kakkad is B.com., CA & CFA.

Experience: He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Dealing function, he was working in the Operations Department of ICICI Prudential AMC.

Funds Managed:


0.10%

Change from previous, NAV as on 17-Aug-2022

Growth: ₹ 19.2000

IDCW: ₹ 14.5200


Investment Strategy

The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Investment Details

Min. Investment (₹) 5,000
Min. Addl Investment (₹) 1,000
Min. SIP Investment (₹) 100
Min. No of Cheques 6
Min. Withdrawal (₹) 1
Min. Balance (₹) --
Lock-in Period Not Applicable
Exit Load 1% for redemption within 15 days

Basic Details

Fund House: ICICI Prudential Mutual Fund
Launch Date: 13-Jul-2018
Return Since Launch: 17.25%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 2,503 Cr (As on 31-Jul-2022)
Expense Ratio: 2.07% (As on 30-Jun-2022)
Risk Grade: --
Return Grade: --
Turnover: 54.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
IDCW11-Aug-20221.4000

 12-Aug-20211.7500
 05-Aug-20201.3000

Contact Information

AMC: ICICI Prudential Asset Management Company Ltd

Address: One BKC , A Wing , 13th Floor, Bandra Kurla Complex, Mumbai - 400051

Fax: 022-26528100

Website: http://www.icicipruamc.com

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

Investors' Hangout

Most-asked mutual fund queries answered

DateFri, 19-Aug-2022
Time12:30 PM - 12:40 PM

attending You have reserved a spot